Home » Biotica, Pfizer End Research Partnership
Biotica, Pfizer End Research Partnership
Biotica Technology has reacquired worldwide rights from Pfizer for its rapamycin analogue program. The program focuses developing treatments for neuro-inflammatory and other diseases.
PMLive
PMLive
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May